Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Boston, MA


The Pediatric Brain Tumor Center at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is a world-renowned destination for children with malignant and non-malignant brain and spinal cord tumors. Our patients receive care from neurologists, neuro-oncologists, neurosurgeons and pediatric subspecialists with extensive expertise in treating these types of childhood cancers.

Contact information


 450 Brookline Ave.  D1622

 Boston, MA  02215-5450

Phone: (617) 632-2291
Fax: (617) 632-2290
E-mail: Dhaas-kogan@LROC.harvard.edu


Principal Investigator
Dr. Chi joined the Pediatric Neuro-Oncology Program at Dana-Farber Cancer Institute and Boston Children’s Hospital in 2003. She is currently the Director of their Pediatric Brain Tumor Clinical Trials Program and is an Assistant Professor of Pediatrics at Harvard Medical School. Dr. Chi’s clinical interests include neuro-oncology, atypical teratoid-rhabdoid tumor (ATRT), and infant brain tumors. Her primary area of interest is the development of clinical trials, in collaboration with larger multi-institutional, collaborative groups, for the treatment of young children with malignant brain tumors, and specifically in exploring novel strategies to treat this young population.
Co-Principal Investigator
Daphne Haas-Kogan, MD is Chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and Boston Children’s Hospital. Dr. Haas-Kogan’s research focuses on aberrant signaling pathways in central nervous system and pediatric tumors and investigates agents that target these signaling cascades. Dr. Haas-Kogan has a broad background in neuro-oncology, radiation oncology, and molecular biology, with specific training and expertise in key research areas for this application. As a translational scientist Dr. Haas-Kogan has taken findings from the laboratory and used them to design clinical trials for adults and children.